Anti-tumor cytostatic mechanism and delayed-type hypersensitivity against a syngeneic murine tumor. Comparison between neonatally thymectomized mice and congenitally athymic nude mice
- PMID: 2493508
Anti-tumor cytostatic mechanism and delayed-type hypersensitivity against a syngeneic murine tumor. Comparison between neonatally thymectomized mice and congenitally athymic nude mice
Abstract
We studied the anti-tumor mechanism against a syngeneic tumor using a BALB/c-MA tumor system by cytolysis and cytostasis assays in vitro comparing mice neonatally thymectomized at 1 day or 7 days after birth (NTx-1, NTx-7), sham-operated (sham) mice, and congenitally athymic nude BALB/c mice. NTx-1 mice showed more rapid tumor growth and a slightly lower degree of strong cytostatic activity in peritoneal exudate cells (PEC) than NTx-7 or sham mice. Nude mice showed more rapid MA growth than NTx-1 mice and no cytostatic activity in PEC. After immunization with mitomycin C-treated MA (MMC-MA), NTx-1 mice acquired an immunoprophylactic capacity against MA and showed cytostatic activity and delayed footpad reaction (DFR) to MA, however, nude mice showed no acquisition of such an immunity, or cytostatic activity, or DFR to MA. These differences between NTx-1 and nude mice could be well-explained by less capacity of nude mice to produce a macrophage-activating factor, which activates macrophages to exert cytostasis and DFR. However, NTx-1 mice could not reject MA by immunization with MMC-MA in CFA (MMC-MA/CFA), although such immunized sham mice could eliminate MA completely. Both PEC and spleen cells from Sham mice immunized with MMC-MA/CFA showed cytostatic activity, whereas NTx-1 mice showed cytostatic activity of the same level in PEC and less in spleen cells compared to Sham mice. Cytolytic activity was never detected throughout this study in a BALB/c-MA system. These data suggest that cytostasis plays an important role in antitumor immunity against a syngeneic MA tumor and that two types of cytostasis is included from the standpoint of thymus-dependency of ontogenic development, relatively low and high.
Similar articles
-
Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.J Clin Lab Immunol. 1986 Feb;19(2):83-9. J Clin Lab Immunol. 1986. PMID: 3083105
-
Role of cytostasis in antitumor immunity against syngeneic X5563 plasmocytoma: comparative study of cytostasis and cytolysis using variant tumors and neonatally thymectomized mice.J Clin Lab Immunol. 1989 May;29(1):45-52. J Clin Lab Immunol. 1989. PMID: 2628584
-
Protective immunity to Listeria monocytogenes in neonatally thymectomized (NTx) mice: involvement of T cells distinct from those in sham-thymectomized mice.Immunology. 1988 Apr;63(4):649-55. Immunology. 1988. PMID: 3259205 Free PMC article.
-
Rejection of syngeneic tumor cells by the interaction of Lyt-1+ T lymphocytes and macrophages.J Clin Lab Immunol. 1985 Oct;18(2):97-101. J Clin Lab Immunol. 1985. PMID: 3935795
-
Where is the immunology in cancer?Aust N Z J Surg. 1978 Feb;48(1):89-92. doi: 10.1111/j.1445-2197.1978.tb05814.x. Aust N Z J Surg. 1978. PMID: 352329 Review.
Cited by
-
Analysis of effector T cells against the murine syngeneic tumor MethA in mice orally administered antitumor polysaccharide SPR-901.Cancer Immunol Immunother. 1994 Mar;38(3):143-8. doi: 10.1007/BF01525634. Cancer Immunol Immunother. 1994. PMID: 7907272 Free PMC article.